跳至主要内容
临床试验/NCT06606184
NCT06606184已完成不适用

Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant

Chang Gung University1 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
78
试验地点
1
主要终点
Respiratory Muscle Stregnth Test

研究概览

简要总结

The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are:

Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation?

Participants performed:

Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise

详细描述

Patients undergoing liver transplantation often face significant challenges related to pulmonary rehabilitation. Although postoperative rehabilitation has been extensively studied, the specific role of pulmonary rehabilitation programs has received limited attention. This study aims to evaluate the efficacy of a home-based pulmonary rehabilitation program in improving respiratory function recovery among post-liver transplant patients. The training group participated in a 12-week pulmonary rehabilitation program post-discharge, emphasizing respiratory muscle and exercise training, while the control group received standard care, which included traditional rehabilitation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20 years or older
  • Scheduled to undergo living donor liver transplantation
  • Stable vital signs
  • Normal cognitive function
  • Able to perform activities independently using their own strength and coordination
  • Willing and able to participate in 12 weeks of rehabilitation training

排除标准

  • Severe physical illness during the operation
  • Acute bleeding
  • Unstable vital signs
  • Hepatic encephalopathy, or neurological conditions such as stroke, Parkinson's disease, or cognitive dysfunction
  • Limited mobility (e.g., unable to stand, lift upper limbs, or bedridden)
  • Inability to comply with 12 weeks of pulmonary rehabilitation post-discharge
  • Unstable vital signs
  • Hepatoencephalopathy, such as cardiovascular accident, Parkinson disease, cognitive dysfunction
  • Those with limited mobility (unable to stand, unable to lift upper limbs, or bedridden)
  • Those who are unable to cooperate with the 12 weeks of pulmonary rehabilitation exercises after discharge.

结局指标

主要结局

Respiratory Muscle Stregnth Test

时间窗: Throughout the study completion, approximately 3 month

Respiratory muscle strength was determined by Maximum Inspiratory Pressure (MIP) using a pressure monometer.

次要结局

  • Oxygenation status(Participants underwent maximum inspiratory and expiratory pressure measurements at four time points: upon admission, before discharge from the intensive care unit, before discharge from the hospital, and at the end of the 12-week enrollment period.)
  • Dyspnea Severity Assessment(Throughout the study completion, approximately 3 month)
  • Forced Vital Capacity(Throughout the study completion, approximately 3 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Ling Lin

Professor

Chang Gung University

研究点 (1)

Loading locations...

相似试验